Navigation Links
Millennium Laboratories Announces New General Counsel Martin Price and Chief Compliance Officer Janna Sipes
Date:6/13/2011

SAN DIEGO, June 13, 2011 /PRNewswire/ -- Millennium Laboratories, a leading provider of medication monitoring services to physicians and staff treating chronic pain, announced today the hiring of Martin Price as General Counsel and Janna Sipes as Senior Vice President, Regulatory Counsel, Chief Compliance Officer.

As Millennium Laboratories General Counsel, Mr. Price will oversee all legal affairs of the company. Howard Appel, Millennium Laboratories' President, said, "We are very pleased to have someone of Martin's caliber join our senior leadership team.  Martin's depth of experience is a natural fit for our values-based culture and our leadership in national medication monitoring and corporate responsibility. We know he will make a tremendous contribution."

Prior to joining Millennium, Mr. Price was a Partner with the international law firm of Hogan Lovells US LLP, where he served as Millennium's outside counsel.  In addition to his work for Millennium, Mr. Price acted as lead counsel on behalf of several Fortune 500 corporations in defending class actions, government investigations, and prosecuting litigation against competitors.  His substantial healthcare expertise covers the full spectrum of federal and state compliance matters for clinical testing laboratories, including the federal Stark and anti-kickback laws, HIPAA, Hi-Tech and state rules and regulation. He holds a B.A. degree from the George Washington University and a M.A. degree from Duke University. He received his J.D. from the George Washington University Law School.

Martin Price commented, "I am excited to join Millennium as General Counsel. The company's outstanding reputation in the clinical laboratory industry is well-known and I am looking forward to an enhanced role with the organization as it continues its remarkable growth."

Price continued, "Janna Sipes brings a wealth of legal experience in life sciences, clinical laboratories, diagnostics and pharmaceuticals to Millennium.  Her regulatory and compliance expertise coupled with her sound business judgment will be a critical asset to our legal department and the company."

Before joining Millennium, Ms. Sipes served as Vice President, Legal and Human Resources, and Compliance Officer with Cypress Bioscience where she developed and oversaw all corporate compliance programs.  She held a similar position with Prometheus Laboratories, Inc., also in San Diego.  She holds a B.S. degree from Texas Tech University and earned her J.D. from Baylor University School of Law.

About Millennium Laboratories

Located in San Diego's life sciences cluster, Millennium Laboratories, Inc. is a national, research-based medication monitoring company whose test offering, technology, customer support, educational resources and experts are specifically focused on clinicians who treat chronic pain.  The company is recognized as a leader in pain management services, setting industry standards in drug testing and reporting, clinical research and education. Millennium serves as an industry educator and a compassionate advocate for pain sufferers throughout the United States. Millennium Laboratories is accredited by The Joint Commission, receiving the Gold Seal of Approval™ for healthcare quality and safety.

Among the numerous scientific and research achievements of the company's renowned laboratory team, Millennium Laboratories' reference laboratory is certified as a training facility for clinical toxicologist scientists and operates as a unique research component of the University of California, San Diego's (UCSD) doctoral program in Pharmacy.

As part of the company's commitment to pain management research and education, Millennium Laboratories established the Millennium Research Institute (MRI), a non-profit, national research center that conducts and disseminates original research focused on improving the experiences of people suffering from pain and pain-related disorders.  Millennium Research Institute maintains several national academic partnerships and supports collaborative research focused on greater understanding of the treatment of pain, improvements to patient safety and identification and prevention of prescription drug abuse.

For more information, visit the Millennium Laboratories website, www.becausepainmatters.com.


'/>"/>
SOURCE Millennium Laboratories, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Millennium Surgicals Smart Instrument Purchasing Saves OR Personnel Time, Money
2. Millennium Laboratories Founder and CEO James Slattery Named Ernst & Young Entrepreneur of the Year® San Diego Finalist
3. Zen Holding Corp. Signs LOI to Acquire Millennium Healthcare Solutions Inc.
4. Millennium Laboratories Launches New Educational Webinar Series for Pain Management Physicians
5. Millennium Laboratories Founder and CEO James Slattery Named Ernst & Young Entrepreneur Of The Year® 2011 Award Semifinalist in San Diego
6. Millennium Surgical adds "SurgicalInstruments.com" Name
7. Technology Embracing Pharmacy, Millennium Pharmacy Systems, Welcomes New CIO
8. Millennium Laboratories to Provide UnitedHealthcares Nationwide Network of Physicians Drug Monitoring and Pain Management Services
9. Pharmacy Industry Veteran Joins Millennium Pharmacy Systems as COO
10. Millennium Research Group to Release Their Latest US Clot Management Data
11. New Peripheral Vascular Device Market Research Data Covering Multiple Geographies Released by Millennium Research Group
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/8/2016)... 8, 2016 KEY FINDINGS ... of the market in 2016 and is expected to ... attributed to a large number of surgical procedures that ... largest share in the patient temperature management market.) Patient ... reducing loss of blood during surgeries, lowering the risks ...
(Date:12/8/2016)... Research and Markets has announced the addition ... Adhesion Type, Application, Usability - Forecast to 2025" report to ... , , ... poised to grow at a CAGR of around 3.2% from 2015 ... witnessing include advancements in extracellular microelectrode arrays and intracellular microelectrodes, research ...
(Date:12/8/2016)... 2016  Valeant Pharmaceuticals International, Inc. (NYSE: ... announced positive results from a Phase 3, multicenter ... safety and efficacy of IDP-118 (halobetasol propionate and ... Within the Phase 3 study ... psoriasis, IDP-118 showed statistical significance to vehicle with ...
Breaking Medicine Technology:
(Date:12/9/2016)... (PRWEB) , ... December 09, 2016 , ... ... whiteboard display solutions, proudly announced today that a new solution for Emergency Departments ... fit in the tight space in Emergency Department examination rooms, and with a ...
(Date:12/8/2016)... Cambridge, MA (PRWEB) , ... December 08, 2016 ... ... the Workers Compensation Research Institute (WCRI) officially opened registration today for its ... Place Hotel in Boston, MA . , The theme of the conference is ...
(Date:12/8/2016)... ... December 08, 2016 , ... CURE Media Group, the nation’s leading digital ... aligned with Upstage Lung Cancer in efforts to combat lung cancer, announced CURE Media ... Jr said, “CURE Media Group is honored to team up with Upstage Lung Cancer ...
(Date:12/8/2016)... (PRWEB) , ... December 08, ... ... Presence Suite 10.2 version gives development continuity to its innovative Unified Instance ... channels management capacity. In addition, this new version optimizes the unattended auto-dialing ...
(Date:12/8/2016)... ... December 08, 2016 , ... Today’s patients are encouraged ... in mind, SIGVARIS has created a new line of anti-embolism stockings to help ... provide the benefits of graduated compression when transitioning from recovery to early rehabilitation. ...
Breaking Medicine News(10 mins):